Overview / Abstract: |
Target Audience This activity is intended for primary care providers, internal-medicine specialists, pediatricians, pulmonologists, cardiologists, endocrinologists, gastroenterologists, hepatologists, neurologists, neuromuscular specialists, infectious-disease specialists, obstetricians/gynecologists, rheumatologists, dermatologists, hematologists, oncologists, neonatologists, genetic counselors, social workers, psychologists, nurse practitioners, physician assistants, nurses, and pharmacists Learning Objectives Upon completion of this activity, participants should be better able to: Cite evidence for the use of gene‐based therapies that are approved or pending approval for the management of medical disorders |
Expiration |
Apr 29, 2022 |
Discipline(s) |
Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Alessandra Biffi, MD Kevin Flanigan, MD Kimberly Goodspeed, MD Stephan A. Grupp, MD, PhD John Kessler, MD Julie A. Parsons, MD Perry B. Shieh, MD, PhD, FAAN |
Sponsors / Supporters / Grant Providers |
Astellas Gene Therapies; AVROBIO, Inc.; Biogen; CRISPR Therapeutics, Inc.; Helixmith Co., Ltd; Orchard Therapeutics; REGENXBIO Inc.; and uniQure, Inc. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Rare Disorders Free CE CME |